For some people living with a leg amputation, the hardest part of wearing a prosthesis is not the artificial foot or knee. It is the socket that holds the prosthesis against the remaining limb. A socket may cause pressure, rubbing, skin breakdown, sweating, instability, or difficulty with walking. Adjustments and modern socket designs help many people, but they do not solve every problem.
Osseointegration is a different way of attaching a prosthetic leg. Instead of suspending the prosthesis from a socket, surgeons place a metal implant into the bone of the residual limb. After healing, the external prosthesis connects to that implant. This is often called a bone-anchored prosthesis or direct skeletal attachment.
The approach is promising for carefully selected patients, but it is a major reconstructive procedure with a substantial rehabilitation commitment and real complications. Not everyone with an amputation needs—or should undergo—osseointegration.
What is osseointegration for an amputated leg?
The word osseointegration describes bone developing a stable connection to an implant surface. For lower-limb prostheses, an implant is placed inside the remaining femur (thighbone) or tibia (shinbone). A connection extends through a carefully managed opening in the skin to attach an external prosthetic limb.
Unlike a conventional socket, which surrounds the residual limb and transfers loads through skin and soft tissues, a bone-anchored system transfers load through the skeleton. Some users report a more secure connection, less socket-related discomfort, and greater confidence with movement. The skin opening and implanted hardware, however, introduce new responsibilities and risks.
This is not the same operation as a hip or knee replacement. A hip or knee replacement substitutes an arthritic joint surface. Osseointegration after amputation anchors a prosthetic limb to a residual bone. Both involve implants, but their purposes, anatomy, and follow-up are different.
Femoral versus tibial osseointegration: what is the difference?
Above-knee amputation: transfemoral osseointegration
A transfemoral amputation leaves part of the femur but removes the natural knee and the leg below it. A bone-anchored implant is inserted into the remaining femur. The external prosthesis generally includes an artificial knee and lower-leg/foot components.
Someone with a short or scarred residual thigh, repeated socket sores, fluctuating limb size, or severe socket intolerance may be evaluated for this approach. The exact length and quality of remaining bone, tissue condition, bone health, rehabilitation ability, and medical history all matter.
Below-knee amputation: transtibial osseointegration
A transtibial amputation preserves the natural knee and some of the tibia. A bone-anchored implant is placed in the remaining shinbone, with the external prosthesis attaching below it. Because the natural knee is retained, the anatomy, forces on the implant, and prosthetic design differ from an above-knee system.
Evidence for transtibial procedures is emerging, but the studied patient populations remain small. An updated 2026 systematic review identified 19 studies involving 102 people with transtibial amputation. It found potential improvements in prosthesis use, mobility, and quality of life, alongside infection concerns and a need for better long-term data. These findings are not a guarantee of benefit for an individual patient.
Who might consider a bone-anchored prosthesis?
The first step is usually to determine whether problems can be addressed with a better socket, prosthetic alignment, skin care, targeted therapy, or other treatment. A specialist team may consider osseointegration when conventional socket use remains significantly limited despite appropriate efforts.
Reasons for a careful evaluation may include:
- Repeated skin irritation, ulceration, or pain from the prosthetic socket.
- Difficulty obtaining a secure fit because of limb shape, scars, grafts, or changes in residual-limb volume.
- Limited prosthesis wear time or mobility because of socket intolerance.
- Difficulty keeping a prosthesis attached during daily activities despite appropriate fitting.
- Goals that cannot reasonably be met with a well-designed conventional socket and rehabilitation program.
An assessment also examines the cause of the amputation, circulation, infection history, bone length and strength, general health, medications, tobacco exposure, and whether the person can safely participate in postoperative care. There is no universal eligibility checklist that applies to every device and every clinical program. Patients with impaired wound healing or higher infection risk may need additional evaluation or may not be good candidates.
What does the research say in 2026?
Evidence is growing, but much of it comes from observational studies at specialized centers, often involving relatively small groups. People selected for surgery may differ from typical socket users, so a favorable average result should not be interpreted as proof that the procedure is better for everyone.
A 2025 five-year follow-up study reported on people receiving contemporary press-fit femoral or tibial osseointegration implants. Among 76 participants available for analysis, five-year implant survival was 94.2%. The same study reported infections in 27 patients and several other complications, including fractures and surgeries around the skin opening. That number describes the studied implants and follow-up period, not the expected survival of every implant or patient.
A 2026 comparative observational study involving 37 adults with transfemoral amputation found improvements in pain, prosthesis use, walking measures, and patient-reported quality of life among the 16 people who underwent surgery for severe socket problems. The comparison group consisted of 21 people already functioning well with sockets. This helps frame possible benefits, but the sample was small and the study was not a randomized trial.
A 2026 transtibial systematic review found encouraging mobility and quality-of-life signals, but also emphasized that high-quality long-term evidence and reliable cost-effectiveness estimates remain limited.
What are the risks and tradeoffs?
The main concern is infection. The connector passes through a permanent opening in the skin, so ongoing care of the skin-implant interface is essential. Superficial infections may be treatable, but deeper infection involving bone or implanted hardware can require surgery and, in some cases, implant removal.
Other important risks include:
- Fracture around the implant or residual bone during a fall or other injury.
- Implant loosening or mechanical failure, sometimes requiring revision surgery.
- Problems with the skin opening, including irritation, excess tissue, drainage, or the need for additional procedures.
- Persistent pain or unexpected limitations, even when the implant remains fixed.
- Time away from usual prosthesis use, a lengthy rehabilitation process, and future follow-up needs.
A 2024 systematic review of femoral and tibial systems documented a wide range of complications and emphasized the need for larger, longer studies. The risk depends on the implant, amputation level, surgical technique, health conditions, and follow-up duration. No percentage from a single study can predict an individual outcome.
What does surgery and rehabilitation involve?
Depending on the system and treatment center, implantation may be completed in one operation or in stages. Treatment generally includes preoperative imaging, assessment of the residual bone and soft tissues, surgical implantation, bone and wound healing, progressive loading, prosthetic fitting, and gait rehabilitation.
The pace of rehabilitation is individualized. It may involve months of structured work with a surgeon, prosthetist, physical therapist, and rehabilitation team. Patients learn how to protect the limb, check the skin opening, manage their device, progress weight bearing, and recognize warning signs. A bone-anchored prosthesis is not an instant return to normal walking.
People living in Hawaiʻi should also consider travel and continuity of care if a specialized surgical center, prosthetist, or rehabilitation program is located off-island. Follow-up access is an important part of whether the treatment is practical.
Is osseointegration FDA-approved for both femoral and tibial amputations?
Device authorization is specific to the implant and its approved use. The U.S. Food and Drug Administration approved the OPRA Implant System in December 2020 for a defined group of skeletally mature patients with transfemoral (above-knee) amputation due to trauma or cancer who cannot adequately use, or are expected to have major problems using, a conventional socket prosthesis. The exact labeling and any updates should be confirmed with the treating center.
That approval must not be read as a blanket FDA approval for every osseointegration device or every below-knee use. Transtibial implants have been studied, but the regulatory status, availability, and eligibility of a proposed device must be checked individually.
Coverage is also not assured. Patients should request a device-specific explanation of potential insurance authorization, treatment-center costs, rehabilitation needs, and follow-up responsibilities before making decisions.
What should you ask at a consultation?
Ask whether socket optimization or other rehabilitation options have been fully explored; which bone-anchored system is being considered and for which amputation level; what the device’s regulatory indication is; what the center’s own infection, fracture, revision, and implant-removal outcomes show; and who will provide prosthetic fitting, physical therapy, and urgent follow-up if a complication occurs.
If you are managing recurrent socket pain or skin breakdown, an orthopedic and rehabilitation evaluation can clarify the underlying problem and whether a specialist referral is appropriate. Availability of osseointegration surgery at Pacific Bone & Joint has not been confirmed here; any procedural referral should be based on verified local services and the patient’s needs.
Takeaway
Bone-anchored prostheses offer a potentially important option for selected people with above- or below-knee amputations who struggle with traditional sockets. The goal is a more stable, usable connection between the body and an artificial leg. Research suggests possible improvements in mobility and quality of life, but infection risk, surgical complications, long-term uncertainty, and rehabilitation demands make careful patient selection essential.
Sources: FDA OPRA approval and indication; 2026 transtibial systematic review; 2026 transfemoral comparative study; 2025 five-year implant outcomes; 2024 complications systematic review.
